Probe Scientific has developed and successfully trialled a disposable blood sampling device capable of automating the blood sampling of critically ill patients with the need for removing whole blood. The product is well placed to benefit from the overall trend for increased screening and testing of patients, and the increasing number of people living with chronic diseases.
The product, MicroEye® will, when combined with suitable sensors at the bedside, give access to continuous biomarker data. In the first instance it has been used to monitor blood glucose.
Probe has benefited from NESTA's initial investment which enabled Probe to undertake Proof of Concept and market acceptance assessments. Latterly a more recent investment has allowed Probe to demonstrate the efficacy and accuracy of the system in a clinical environment and to build a lab based demonstration system.
Neil Smith, CEO
T +44 (0)20 7438 2500
F +44 (0)20 7438 2501
Nesta Operating Company, a company limited by guarantee registered in England and Wales with company number 7706036 and charity number 1144091. Registered as a charity in Scotland number SC042833.
